These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 12905508

  • 1. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
    Chasen ST, Sharma G, Kalish RB, Chervenak FA.
    Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
    [Abstract] [Full Text] [Related]

  • 2. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population.
    Brizot ML, Carvalho MH, Liao AW, Reis NS, Armbruster-Moraes E, Zugaib M.
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):652-5. PubMed ID: 11844209
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
    Gasiorek-Wiens A, Tercanli S, Kozlowski P, Kossakiewicz A, Minderer S, Meyberg H, Kamin G, Germer U, Bielicki M, Hackelöer BJ, Sarlay D, Kuhn P, Klapp J, Bahlmann F, Pruggmayer M, Schneider KT, Seefried W, Fritzer E, von Kaisenberg CS, German-Speaking Down Syndrome Screening Group.
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
    [Abstract] [Full Text] [Related]

  • 5. [Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland].
    Tercanli S, Holzgreve W, Batukan C, Gerber A, Ermis H, Miny P.
    Ultraschall Med; 2002 Feb; 23(1):22-6. PubMed ID: 11842368
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
    Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH.
    Lancet; 1998 Aug 01; 352(9125):343-6. PubMed ID: 9717920
    [Abstract] [Full Text] [Related]

  • 8. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 1999 Apr 01; 13(4):231-7. PubMed ID: 10341399
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Establishment and application of a normal range for nuchal translucency across the first trimester.
    Scott F, Boogert A, Sinosich M, Anderson J.
    Prenat Diagn; 1996 Jul 01; 16(7):629-34. PubMed ID: 8843472
    [Abstract] [Full Text] [Related]

  • 12. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
    Schwärzler P, Carvalho JS, Senat MV, Masroor T, Campbell S, Ville Y.
    Br J Obstet Gynaecol; 1999 Oct 01; 106(10):1029-34. PubMed ID: 10519427
    [Abstract] [Full Text] [Related]

  • 13. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P, Sonek J, Hoopmann M, Abele H, Kagan KO.
    Ultrasound Obstet Gynecol; 2016 Oct 01; 48(4):446-451. PubMed ID: 26611869
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B, Sairam S, Michailidis G, Wathen NC.
    Br J Radiol; 1999 Oct 01; 72(862):946-8. PubMed ID: 10673944
    [Abstract] [Full Text] [Related]

  • 16. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
    Soergel P, Pruggmayer M, Schwerdtfeger R, Muhlhaus K, Scharf A.
    Fetal Diagn Ther; 2006 Oct 01; 21(3):264-8. PubMed ID: 16601335
    [Abstract] [Full Text] [Related]

  • 17. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
    Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Apr 01; 31(4):376-83. PubMed ID: 18383462
    [Abstract] [Full Text] [Related]

  • 18. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O.
    Ultrasound Obstet Gynecol; 2005 Mar 01; 25(3):221-6. PubMed ID: 15736186
    [Abstract] [Full Text] [Related]

  • 19. Nuchal translucency thickness measurements for fetal aneuploidy screening: Log NT-MoM or Delta-NT, performer-specific medians and ultrasound training.
    Gyselaers WJ, Vereecken AJ, Van Herck EJ, Straetmans DP, Ombelet WU, Nijhuis JG.
    J Med Screen; 2006 Mar 01; 13(1):4-7. PubMed ID: 16569298
    [Abstract] [Full Text] [Related]

  • 20. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F, Dommergues M, Benattar C, Taieb J, Thalabard JC, Frydman R.
    Ultrasound Obstet Gynecol; 2001 Jul 01; 18(1):26-31. PubMed ID: 11489221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.